Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-14-006824
Filing Date
2014-11-19
Accepted
2014-11-19 14:36:31
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 170496
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4383
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 4377
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2036
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2030
  Complete submission text file 0001062993-14-006824.txt   1885440

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cydi-20140930.xml EX-101.INS 108903
7 XBRL CALCULATION FILE cydi-20140930_cal.xml EX-101.CAL 39657
8 XBRL DEFINITION FILE cydi-20140930_def.xml EX-101.DEF 141702
9 XBRL LABEL FILE cydi-20140930_lab.xml EX-101.LAB 290190
10 XBRL PRESENTATION FILE cydi-20140930_pre.xml EX-101.PRE 154963
11 XBRL SCHEMA FILE cydi-20140930.xsd EX-101.SCH 35081
Mailing Address 401 ROSEMONT AVENUE - FREDERICK MD 21701
Business Address 401 ROSEMONT AVENUE - FREDERICK MD 21701 301-644-3901
Cybrdi, Inc. (Filer) CIK: 0000019002 (see all company filings)

EIN.: 952461404 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-09081 | Film No.: 141234690
SIC: 2836 Biological Products, (No Diagnostic Substances)